Establishment of Immuno-oncology as a Cancer Therapy
Immuno-oncology is set to become one of the most vital cancer treatments, rising up into the realms surgery, chemotherapy, radiotherapy, and other targeted therapies. From their study, “Pharma Focus Visual Analysis of Immuno-Oncology Development and Opportunities”, Global Data was able to reach a conclusion and has analyzed more than 4,000 clinical trials of over 800 […]
Continue readingWhat is Immuno-Oncology?
The immune system is a collection of molecules in every living thing that protects its cells. It relies on the ability to tell the difference between its own body cells and foreign cells, called antigens, in order to protect the body from the harmful antigens. The immune system has a set of proteins commonly […]
Continue readingAdvancements in Immunotherapy Changing the Landscape of Cancer Treatment
Cancer patients have a better chance at beating diseases with the help of immunotherapy, a type of cancer treatment, as studies are now showing. Two new immunotherapy drugs have recently been approved by the Food and Drug Administration last March. One of the immunotherapies approved is Keytruda, which is made to treat Hodgkin’s lymphoma for […]
Continue readingEuropean Committee Approves Opdivo Advance
Opdivo Advances in Europe In response to the decision made in the United States last March, manufacturer Bristol-Myers Squibb has announced a new dosing schedule for Opdivo (nivolumab), recommended by the Committee for Medicinal Products for Human Use of the European Medicines Agency. This new dosing schedule lets physicians choose to prescribe Opdivo as a […]
Continue readingProof of Concept Established for New Cancer Vaccine
A company called Nanobiotix has established proof of concept (POC) for a new product in the fight against cancer. Proof of concept means that there is evidence that the new drug could be effective. The product is a new and innovative way to fight cancer at the cellular level. The product is called NBTXR3 and […]
Continue reading